Jay Parrish, Chief Business Officer at Vir Biotechnology, Inc. (VIR), sold 13,890 shares at $34.75 ($483K) on 2020-10-01, disclosed to the SEC on 2020-10-02.
Open-market sale of $483k VIR by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $34.75 | 6,945 | $241K | 50.0% |
| 2 | $34.75 | 6,945 | $241K | 50.0% |
| Total | $34.75 avg | 13,890 | $483K | 100% |
| Filing → |
| VIR | SELL | 2021-02-02 | $971K | — | Filing → |
| VIR | SELL | 2021-01-05 | $366K | — | Filing → |
| VIR | SELL | 2020-12-02 | $438K | — | Filing → |